Dulcolax and Progesterone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dulcolax (bisacodyl) and Progesterone (progesterone). Common drug interactions include nausea among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Dulcolax and Progesterone. It is created by eHealthMe based on reports of 63 people who take the same drugs from the FDA, and is updated regularly.

What is Dulcolax?

Dulcolax has active ingredients of bisacodyl. It is often used in constipation. eHealthMe is studying from 12,897 Dulcolax users. Check the latest studies of Dulcolax.

What is Progesterone?

Progesterone has active ingredients of progesterone. It is often used in menopause. eHealthMe is studying from 21,021 Progesterone users. Check the latest studies of Progesterone.

On Jul, 16, 2026

63 people who take Dulcolax and Progesterone together, and have interactions are studied.

Dulcolax and Progesterone drug interactions.

What are the common drug interactions of Dulcolax and Progesterone, by gender? *:

female:

Nausea (feeling of having an urge to vomit)
Rash
Gait disturbance
Fatigue (feeling of tiredness)
Speech disorder
Pruritus (severe itching of the skin)
Neuropathy peripheral (surface nerve damage)
Pain in extremity
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Ataxia (loss of full control of bodily movements)

male:

Asthenia (weakness)
Confusional state
Tooth infection
Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
Dehydration (dryness resulting from the removal of water)
Fatigue (feeling of tiredness)
Febrile neutropenia (fever with reduced white blood cells)
Glomerulonephritis membranous (nephritis with inflammation of the capillary loops in the renal glomeruli)
Hypoglycaemia (deficiency of glucose in the bloodstream)
Localised infection (infection at the single location)

What are the common drug interactions of Dulcolax and Progesterone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Catheter site infection (infection at the site of insertion)
Dizziness
Catheter site erythema (redness of skin at catheter site)
Catheter site pain
Chest discomfort
Chest pain
Dyspnoea (difficult or laboured respiration)
Erythema (redness of the skin)
Fall
Fatigue (feeling of tiredness)

40-49:

Bacterial infection
Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
Complex regional pain syndrome (long lasting pain condition most often affecting one of the limbs (arms, legs, hands, or feet))
Folate deficiency (lack of folic acid)
Intervertebral disc protrusion (spinal disc protrusion)
Iron deficiency
Migraine (headache)
Oral pain
Peroneal nerve palsy
Scar

50-59:

Speech disorder
Fatigue (feeling of tiredness)
Vomiting
Nausea (feeling of having an urge to vomit)
Bk virus infection
Blood creatinine decreased
Catheter site haemorrhage (bleeding at catheter site)
Headache (pain in head)
Pain in extremity
Blood pressure increased

60+:

Nausea (feeling of having an urge to vomit)
Rash
Pain
Pain in extremity
Rib fracture
Upper limb fracture
Arthralgia (joint pain)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cough
Decreased appetite

What are the existing conditions these people have? *

Fabry's Disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells): 21 people, 33.33%
Pain: 11 people, 17.46%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 8 people, 12.70%
Asthma: 8 people, 12.70%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 7 people, 11.11%
Lipidosis (disorder of lipid metabolism involving abnormal accumulation of lipids in the reticuloendothelial cells): 7 people, 11.11%
Immunodeficiency Common Variable: 6 people, 9.52%
High Blood Pressure: 6 people, 9.52%
Sinusitis (inflammation of sinus): 6 people, 9.52%
Osteoporosis (bones weak and more likely to break): 6 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Dulcolax and Progesterone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously